Portfolio

Home / Archive by category "Portfolio"
Figure 8

Figure 8

Headquartered in New York, NY, Figure8 (creators of the Museum of Ice Cream) is an experience-first development company to realize, recognize, and reignite relationships with the people and places around them. The company is built on core tenets of imagination, connection, and creativity.

www.museumoficecream.com

Social Native

Social Native

Headquartered in Los Angeles, CA, Social Native is an online platform that enables its users to create customized branded content by connecting with relevant creators, based on interests and brand affinity.

socialnative.com

Finch

Finch

Headquartered in Somerville, MA, Finch Therapeutics is a mission-driven microbiome engineering company developing novel microbial therapies using machine-learning algorithms informed by successful clinical experience to serve patients with serious and unmet medical needs.

finchtherapeutics.com

Invoice2go

Invoice2go

Headquartered in Redwood City, CA and Sydney, Australia, Invoice2go is a subscription based mobile app that helps small business owners win jobs, track payments, and offer their clients the ability to pay any way.

invoice.2go.com

Red Carpet

Red Carpet

Headquartered in Los Angeles, CA, Red Carpet is a luxury concierge movie service bringing first-run movies into the homes of qualified individuals.

www.redcarpethomecinema.com

SafeBreach

SafeBreach

Headquartered in Sunnyvale, CA, SafeBreach is a Cybersecurity company that provides Automated Breach and Attack Simulation solutions to enterprise customers.

safebreach.com

ByHeart

ByHeart

Headquartered in New York City, NY, ByHeart is a fully integrated infant nutrition company dedicated to translating leading nutrition science and breastmilk research into products that set the best foundation for babies’ health.

byheart.com

1200 Pharma

1200 Pharma

Headquartered in Pasadena, CA, 1200 Pharma is developing novel oncology therapeutics utilizing breakthrough medicinal chemistry technology from Caltech and proprietary biomarker-driven assays from UCLA to dramatically accelerate pre-clinical drug discovery and clinical approval timelines.